| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 02/07/2013 | CA2842719A1 Novel estrogen receptor ligands |
| 02/06/2013 | EP2552889A1 Fungicidal iminoderivatives |
| 02/06/2013 | EP2552888A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion" |
| 02/06/2013 | CN102918026A Fungicidal iminoderivatives |
| 02/05/2013 | US8368062 Nitrogen-containing heterocyclic compound and organic electronic device using the same |
| 01/31/2013 | WO2013016321A1 Minor groove binder phosphoramidites and methods of use |
| 01/31/2013 | US20130029964 [5, 6] heterocyclic compound |
| 01/31/2013 | US20130029846 Fungicidal Iminoderivatives |
| 01/30/2013 | EP2550255A1 Imaging agents for detecting neurological disorders |
| 01/30/2013 | CN102906074A Fused imidazole derivative |
| 01/29/2013 | US8362270 Self-assembled nanostructures |
| 01/29/2013 | US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 01/29/2013 | US8362068 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors |
| 01/29/2013 | US8362056 4-heteroaryl-substituted phenoxyphenylacetic acid derivatives |
| 01/29/2013 | US8362047 Anti-cancer agents based on 4-(hetero)Ary1-1,2,5-oxadiazol-3-yl Amino derivatives and a method of making |
| 01/29/2013 | US8362006 Processes for making zilpaterol and salts thereof |
| 01/29/2013 | US8361959 Spiro-imidazolone derivatives as glucagon receptor antagonists |
| 01/24/2013 | WO2012103226A3 Bendamustine formulations |
| 01/23/2013 | EP2549837A1 Method for producing organic electroluminescence element |
| 01/23/2013 | CN102887836A L-phenylglycine derivative and application thereof |
| 01/23/2013 | CN102229568B Preparation and use for phenyl ether-bridged N-heterocyclic carbene metal complex |
| 01/22/2013 | CA2565695C Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder |
| 01/17/2013 | US20130018039 Imidazolyl-imidazoles as kinase inhibitors |
| 01/16/2013 | EP2545923A1 Antibacterial agents |
| 01/16/2013 | CN102884054A Fluoroalkyl-substituted 2-amidobenzimidazoles and the use thereof for boosting stress tolerance in plants |
| 01/16/2013 | CN102219744B Preparation method of telmisartan intermediate and intermediate compound |
| 01/15/2013 | US8354543 Process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof |
| 01/15/2013 | US8354542 Heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device |
| 01/15/2013 | US8354434 Cyclourea compounds as calcium channel blockers |
| 01/15/2013 | US8354397 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 01/15/2013 | CA2547391C Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 01/10/2013 | WO2013005157A1 Sulfone derivatives and their use as pkm2 modulators for the treatment of cancer |
| 01/10/2013 | US20130012434 Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use |
| 01/09/2013 | EP2542534A1 Deuterated tetrahydronaphthalene derivatives |
| 01/09/2013 | EP2542533A1 Fluoroalkyl-substituted 2-amidobenzimidazoles and the use thereof for boosting stress tolerance in plants |
| 01/09/2013 | CN102863392A Method for greatly reducing amount of solvent usage in production process of oxfendazole |
| 01/09/2013 | CN102863391A Compound containing 4-N-substituted phenyl-benzimidazole and preparation method thereof |
| 01/09/2013 | CN102863390A Synthetic method of benzimidazole derivatives |
| 01/09/2013 | CN102863389A Method for synthesizing benzimidazole compound |
| 01/09/2013 | CN102180841B 2-bromodifluoromethyl substituted 1,3-oxazoline compound and synthesis method thereof |
| 01/08/2013 | US8350076 Sodium channel blockers |
| 01/03/2013 | WO2013000395A1 Novel histone deacetylase inhibitor of benzamides and use thereof |
| 01/03/2013 | WO2012116151A3 Vinyl -aryl - sulfones for use in peritoneal carcinomatosis |
| 01/03/2013 | US20130005739 Pharmaceutical preparations comprising a cos releasing compound |
| 01/03/2013 | US20130004509 BRAF Mutations Conferring Resistance to BRAF Inhibitors |
| 01/02/2013 | EP2539316A1 Latent acids and their use |
| 01/02/2013 | CN102858742A Trpv1 vanilloid receptor antagonists with a bicyclic portion |
| 01/02/2013 | CN102850278A Method for decoloring imidazole anthelmintics |
| 01/02/2013 | CN102850254A UV-curable monomer and its preparation method, polymerizable composition and backlight module |
| 01/02/2013 | CN102850236A Novel benzamide histone deacetylase inhibitor and application thereof |
| 01/02/2013 | CN101675036B Dual-acting benzoimidazole antihypertensive agents |
| 01/02/2013 | CN101516856B Heterocyclic bridged biphenyls and their use in oleds |
| 01/02/2013 | CN101511797B Benzimidazole modulators of VR1 |
| 01/01/2013 | US8344155 Chemical compounds |
| 12/27/2012 | WO2012177914A1 Polyphenylene host compounds |
| 12/27/2012 | WO2012177618A1 Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto |
| 12/27/2012 | WO2012176818A1 Organic electroluminescent element |
| 12/27/2012 | WO2012176214A2 Process for bendamustine hydrochloride |
| 12/27/2012 | US20120330025 Triarylamine Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device |
| 12/27/2012 | CA2839956A1 Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto |
| 12/26/2012 | CN202621135U Condensation kettle for carbendazim production |
| 12/26/2012 | CN202621134U Feeding and measuring device of carbendazim condensation reaction kettle group |
| 12/26/2012 | CN102050791B Key intermediate of telmisartan, synthesis method thereof and method for synthesizing telmisartan by intermediate |
| 12/26/2012 | CN101855214B Benzimidazole derivatives and their use as FXR agonists |
| 12/26/2012 | CN101812021B Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same |
| 12/26/2012 | CN101804047B Antimicrobial and radioprotective compounds |
| 12/26/2012 | CN101626765B Transcription factor modulating compounds and methods of use thereof |
| 12/20/2012 | WO2012173011A1 Organic electric-field light-emitting element, light-emitting material for organic electric-field light-emitting element, and light-emitting device, display device, and illumination device using same element |
| 12/20/2012 | US20120322830 Cyclourea Compounds as Calcium Channel Blockers |
| 12/20/2012 | CA2850137A1 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon |
| 12/19/2012 | EP2535340A2 Process for making zilpaterol and salts thereof |
| 12/19/2012 | CN102827084A Preparation method of 2-(dichloromethyl)benzimidazole |
| 12/19/2012 | CN102827083A Preparation method of 2-methylbenzimidazole |
| 12/19/2012 | CN102250012B Process for preparing benzimidazole insectifuge oxibendazole |
| 12/18/2012 | US8334316 Substituted organosulfur compounds and methods of using thereof |
| 12/13/2012 | US20120316201 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 12/13/2012 | US20120316197 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases |
| 12/13/2012 | US20120313083 6,12-dinaphthylchrysene derivative and organic light-emitting device using the derivative |
| 12/12/2012 | CN102816121A Use of 1-acyl-3-isopropenylbenzimidazolone derivative as antibacterial medicine |
| 12/12/2012 | CN102816120A Technology for synthesizing 2-(1-hydroxyethyl) benzimidazole |
| 12/12/2012 | CN102250013B Preparation method of albendazole |
| 12/12/2012 | CN102026637B Lipoprotein lipase-activating compositions comprising benzene derivates |
| 12/12/2012 | CN101243054B Synergistic composition amd method for inhibiting growth of microorganisms |
| 12/11/2012 | US8329914 Cyclic benzimidazole derivatives useful as anti-diabetic agents |
| 12/11/2012 | US8329737 Benzimidazoles as selective kinase inhibitors |
| 12/06/2012 | WO2012165314A1 Amide compound |
| 12/06/2012 | US20120309794 Compounds inhibitors of enzyme lactate dehydrogenase (ldh) and pharmaceutical compositions containing these compounds |
| 12/06/2012 | US20120309738 Novel compounds |
| 12/06/2012 | US20120309736 Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 12/06/2012 | US20120306727 Fused polycyclic compound and organic light-emitting device using the compound |
| 12/05/2012 | EP2530071A1 Fused polycyclic compound and organic light-emitting device using the compound |
| 12/05/2012 | CN102807509A Fused polycyclic compound and organic light-emitting device using the compound |
| 12/04/2012 | US8324235 Heterocyclic spiro-compounds |
| 12/04/2012 | US8324213 Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators |
| 12/04/2012 | CA2548323C Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 11/29/2012 | WO2012162635A1 Metabotropic glutamate receptors 5 modulators and methods of use thereof |
| 11/29/2012 | WO2012102937A3 Benz imidazole compounds that expand hematopoietic stem cells |
| 11/29/2012 | WO2010128516A3 Process for the preparation of flibanserin involving novel intermediates |
| 11/29/2012 | US20120301427 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 11/29/2012 | CA2837312A1 Metabotropic glutamate receptor 5 modulators and methods of use thereof |